Litzow, Mark R <br/><br/>
Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?  [electronic resource] 

 -  Best practice & research. Clinical haematology  12 2016 
 - 345-350 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1924 
<br/><br/><label>Standard No.: </label>10.1016/j.beha.2016.10.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allografts<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Imatinib Mesylate--therapeutic use<br/>Philadelphia Chromosome<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--therapy